TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 YEARS CONSIDERED FOR THE STUDY
2.3 CURRENCY AND PRICING
2.4 RESEARCH METHODOLOGY
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 DBMR MARKET CHALLENGE MATRIX
2.8 SECONDARY SOURCES
2.9 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GOVERNMENT INITATIVES TO ENCOURAGE USE OF ELECTRONIC HEALTH RECORDS
5.1.2 INTRODUCTION OF NEW SOLUTIONS AND SERVICES IN HEALTHCARE ANALYTICS
5.1.3 ENTRY OF BIG DATA INTO HEALTHCARE
5.1.4 GROWING NEED TO CURB HEALTHCARE SPENDING WITH BETTER CLINICAL OUTCOMES
5.2 RESTRAINT
5.2.1 LESS NUMBER OF SKILLED PERSONNEL
?
5.3 OPPORTUNITIES
5.3.1 GROWING AWARENESS ABOUT ANALYTICS IN VALUE AND PRECISION BASED CARE
5.3.2 INCREASE IN CLOUD BASED ANALYTICS
5.3.3 INCREASING IMPACT ON HEALTHCARE INDUSTRY DUE TO SOCIAL MEDIA
5.3.4 RISING PATIENT REGISTRIES
5.4 CHALLENGES
5.4.1 DATA CONFIDENTIALITY
5.4.2 ISSUES IN DATA ACCURACY AND CONSISTENCY
5.4.3 DATA INTEGRATION
5.4.4 FUNCTIONING GAP BETWEEN THE PROVIDERS AND PAYERS
6 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY TYPE
6.1 OVERVIEW
6.2 PRESCRIPTIVE ANALYTICS
6.3 PREDICTIVE ANALYTICS
6.4 DESCRIPTIVE ANALYTICS
7 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SERVICES
7.2.1 SUPPORT SERVICES
7.2.2 BUSINESS ANALYTICS SERVICES
7.3 SOFTWARE
7.4 HARDWARE
8 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY DELIVERY MODEL
8.1 OVERVIEW
8.2 ON-DEMAND
8.3 ON-PREMISE
9 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 CLINICAL ANALYTICS
9.2.1 REGULATORY REPORTING AND COMPLIANCE
9.2.2 QUALITY IMPROVEMENT AND CLINICAL BENCHMARKING
9.2.3 CLINICAL DECISION SUPPORT
9.2.4 COMPARATIVE ANALYTICS/ EFFECTIVENESS
9.2.5 PRECISION HEALTH
?
9.3 POPULATION HEALTH ANALYTICS
9.3.1 POPULATION CARE MANAGEMENT
9.3.2 POPULATION RISK MANAGEMENT
9.3.3 PATIENT ENGAGEMENT
9.3.4 CLINICAL OUTCOME MANAGEMENT
9.3.5 ACTIVITY-BASED COSTING
9.4 FINANCIAL ANALYTICS
9.4.1 PAYMENT INTEGRITY AND FRAUD, WASTE, AND ABUSE (FWA)
9.4.2 REVENUE CYCLE MANAGEMENT (RCM)
9.4.3 RISK ADJUSTMENT AND RISK ASSESSMENT
9.4.4 CLAIMS PROCESSING
9.5 OPERATIONAL AND ADMINISTRATIVE ANALYTICS
9.5.1 SUPPLY CHAIN ANALYTICS
9.5.2 WORKFORCE ANALYTICS
9.5.3 RESEARCH ANALYTICS
9.5.4 MARKET INTELLIGENCE
9.5.5 ENTERPRISE PERFORMANCE
9.5.6 STRATEGIC ANALYTICS
10 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY END USER
10.1 OVERVIEW
10.2 HEALTHCARE PAYERS
10.2.1 GOVERNMENT AGENCIES
10.2.2 PRIVATE INSURANCE COMPANIES
10.2.3 EMPLOYERS AND PRIVATE EXCHANGES
10.3 HEALTHCARE PROVIDERS
10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
10.3.2 AMBULATORY SETTINGS
10.3.3 POST-ACUTE CARE ORGANIZATIONS
10.4 ACOS, HIES, MCOS AND TPAS
11 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET, BY GEOGRAPHY
11.1 OVERVIEW
11.2 MIDDLE EAST & AFRICA
11.2.1 SOUTH AFRICA
11.2.2 REST OF MIDDLE EAST & AFRICA
11.2.3 EGYPT
11.2.4 SAUDI ARABIA
11.2.5 UNITED ARAB EMIRATES
11.2.6 ISRAEL
12 MIDDLE EAST & AFRICA HEALTHCARE ANALYTICS MARKET,
COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS; MIDDLE EAST & AFRICA
13 COMPANY PROFILES
13.1 ALLSCRIPTS
13.1.1 COMPANY OVERVIEW
13.1.2 REVENUE ANALYSIS
13.1.3 PRODUCT PORTFOLIO
13.1.4 RECENT DEVELOPMENTS
13.2 OPTUM INC.
13.2.1 COMPANY OVERVIEW
13.2.2 GEOGRAPHICAL PRESENCE
13.2.3 PRODUCT PORTFOLIO
13.2.4 RECENT DEVELOPMENTS
13.3 ORACLE
13.3.1 COMPANY OVERVIEW
13.3.2 REVENUE ANALYSIS
13.3.3 PRODUCT PORTFOLIO
13.3.4 RECENT DEVELOPMENTS
13.4 CERNER
13.4.1 COMPANY OVERVIEW
13.4.2 REVENUE ANALYSIS
13.4.3 PRODUCT PORTFOLIO
13.4.4 RECENT DEVELOPMENTS
13.5 CITIUSTECH INC.
13.5.1 COMPANY OVERVIEW
13.5.2 GEOGRAPHICAL PRESENCE
13.5.3 PRODUCT PORTFOLIO
13.5.4 RECENT DEVELOPMENTS
13.6 WIPRO LIMITED
13.6.1 COMPANY SNAPSHOT
13.6.2 REVENUE ANALYSIS
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 VITREOSHEALTH
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 SCIO HEALTH ANALYTICS
13.8.1 COMPANY SNAPSHOT
13.8.2 PRODUCT PORTFOLIO
13.8.3 RECENT DEVELOPMENTS
13.9 HEALTHCARE CATALYST
13.9.1 COMPANY SNAPSHOT
13.9.2 GEOGRAPHICAL PRESENCE
13.9.3 PRODUCT PORTFOLIO
13.9.4 RECENT DEVELOPMENTS
13.10 GE HEALTHCARE
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 PRODUCT PORTFOLIO
13.10.4 RECENT DEVELOPMENTS
13.11 IBM
13.11.1 COMPANY OVERVIEW
13.11.2 REVENUE ANALYSIS
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 INOVALON
13.12.1 COMPANY OVERVIEW
13.12.2 REVENUE ANALYSIS
13.12.3 PRODUCT PORTFOLIO
13.12.4 RECENT DEVELOPMENTS
13.13 VERSCEND TECHNOLOGIES INC.
13.13.1 COMPANY OVERVIEW
13.13.2 GEOGRAPHIC PRESENCE
13.13.3 PRODUCT PORTFOLIO
13.13.4 RECENT DEVELOPMENTS
13.14 MCKESSON CORPORATION
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 PRODUCT PORTFOLIO
13.14.4 RECENT DEVELOPMENTS
13.15 SAS INSTITUTE
13.15.1 COMPANY OVERVIEW
13.15.2 REVENUE ANALYSIS
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 IKON-TECH
13.16.1 COMPANY OVERVIEW
13.16.2 PRODUCT PORTFOLIO
13.16.3 RECENT DEVELOPMENTS
13.17 IQVIA
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 PRODUCT PORTFOLIO
13.17.4 RECENT DEVELOPMENTS
14 RELATED REPORTS